Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

9

Revenue 2014

Gilead Sciences

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Gilead Sciences' 2013 sales performance.

Regeneron drops RSV drug

Regeneron drops RSV drug

candidates including Johnson &Johnson's lumicitabine which is in phase II testing and hopefuls from Gilead, Aviragen and Ark Bioscience, among others.

People at-risk of HIV in England could get PrEP from September

People at-risk of HIV in England could get PrEP from September NHS England has started what it says is the world's largest single trial of a Gilead-developed therapy that protects high-risk patients from contracting HIV. ... The study of Gilead's pre-exposure prophylaxis (PrEP) therapy Truvada (emtricitabine and

Audit exposes gaps in pharma's promises on trial transparency

Audit exposes gaps in pharma's promises on trial transparency At the other end of the scale lie Valeant, Sigma-Tau, Gilead, Esteve, Dainippon Sunitomo, Alkermes and Abbott - all of which scored zero on the policy transparency index.

Baricitinib delay casts a pall over Lilly's results update

Baricitinib delay casts a pall over Lilly's results update will be beaten to market by other rivals such as Gilead Sciences' filgotinib and AbbVie's upadacitinib ( ABT-494).

Gilead gets OK for three-in-one hep C salvage therapy in US

Gilead gets OK for three-in-one hep C salvage therapy in US Gilead gets OK for three-in-one hep C salvage therapy in US. ... Gilead has also filed for the sofosbuvir, velpatasvir and voxilaprevir therapy in the EU, winning an accelerated review from the EMA in January.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Patient Support Blog Series: Step two to a successful patient support programme
Break down those silos and work across internal and external stakeholders!...
Unfolding the story as two great brands unite for the good of patients
A case study by Create Health...
Innovation Hack
Hacking Innovation
RB’s Lions Health event saw teams compete to protect children in China from air pollution...

Infographics